Genprex Story

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:3em;'>GNP</div>
GNPX -- USA Stock  

USD 3.39  0.03  0.89%

Genprex Stock News module provides quick insight into current market opportunities from investing in Genprex. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Genprex stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Please check Genprex Hype Analysis, Genprex Correlation and Genprex Performance.

Search Today's Stock News

 
Refresh
Genprex stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genprex daily returns and investor perception about the current pice of Genprex as well as its diversification or hedging effects on your existing portfolios.
Acquisition by Varner John Rodney of 530000 shares of Genprex subject to Rule 16b-3
Filed transaction by Genprex Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Genprex insider trading alert for grant of stock option (right to buy) by Varner John Rodney, President & CEO, on 25th of August 2020. This event was filed by Genprex Inc with SEC on 2020-08-25. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Shares Owned by Insiders

Shares Owned by Insiders Comparative Analysis

Genprex is currently under evaluation in shares owned by insiders category among related companies. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Peers

Genprex Related Equities

NKNantKwest   6.85   
0%
100.0%
DYAIDYADIC INTERNATIONAL INC   4.44   
0%
64.0%
DMACDiaMedica Therapeutics   2.38   
0%
34.0%
DTILPrecision BioSciences   1.90   
0%
27.0%
EDITEditas Medicine   1.55   
0%
22.0%
DNLIDenali Therapeutics   0.54   
0%
7.0%
EQEquillium   0.52   
0%
7.0%
DVAXDynavax Technologies Corporation   0.95   
13.0%
0%
DRNADicerna Pharmaceuticals   1.42   
20.0%
0%
EARSAuris Medical Holding   3.33   
48.0%
0%
Please check Genprex Hype Analysis, Genprex Correlation and Genprex Performance. Please also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.